Impaired Rectal Sensation at Anal Manometry Is Associated With Anal Incontinence One Year After Primary Sphincter Repair in Primiparous Women

In a retrospective postal study of 27 women who have developed carpal tunnel syndrome (CTS) in the puerperium, the condition was found to affect predominantly elderly primiparous women (mean age 31.5 years). The condition was associated with breastfeeding in 24 women. The three who did not breastfeed had less severe symptoms which resolved within one month of onset. The symptoms developed a mean of 3.5 weeks following delivery, lasted 6.5 months and started to resolve within 14 days of weaning. Symptomatic treatments with either splint-age, diuretics, non-steroidal anti-inflammatory drugs or steroid injections provided some benefit. Two patients required surgical decompression. All patients were symptom-free by one year.

Download Full-text

Three-dimensional transperineal ultrasound findings associated with anal incontinence after intrapartum sphincter tears in primiparous women

Ultrasound in Obstetrics and Gynecology ◽

10.1002/uog.10072 ◽

2011 ◽

Vol 39 (1) ◽

pp. 83-90 ◽

Cited By ~ 34

Author(s):

D. V. Valsky ◽

S. M. Cohen ◽

M. Lipschuetz ◽

D. Hochner-Celnikier ◽

S. Yagel

Keyword(s):

Anal Incontinence ◽

Three Dimensional ◽

Transperineal Ultrasound ◽

Ultrasound Findings ◽

Primiparous Women

Download Full-text

Mo1563 - Transcutaneous Neuromodulation Improves Impaired Rectal Sensation in Patients with Chronic Constipation

Gastroenterology ◽

10.1016/s0016-5085(18)32614-3 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-753-S-754

Author(s):

Ye Xiao ◽

Lin Lin ◽

Feng Xu ◽

Jiande Chen

Keyword(s):

Chronic Constipation ◽

Rectal Sensation ◽

Impaired Rectal Sensation

Download Full-text

Dynamic 2-dimensional transperineal ultrasound evaluation in labor room as a screening tool for anal sphincter injuries and anal incontinence in primiparous women

American Journal of Obstetrics & Gynecology MFM ◽

10.1016/j.ajogmf.2019.100037 ◽

2019 ◽

Vol 1 (3) ◽

pp. 100037

Author(s):

Federica Bellussi ◽

Elisa Montaguti ◽

Aly Youssef ◽

Ginevra Salsi ◽

Tullio Ghi ◽

...

Keyword(s):

Anal Sphincter ◽

Anal Incontinence ◽

Screening Tool ◽

Transperineal Ultrasound ◽

Ultrasound Evaluation ◽

Primiparous Women

Download Full-text

Clinical outcome of post placental copper T380A and copper 375 IUCD insertion in women delivering by caesarean section

International Journal of Reproduction Contraception Obstetrics and Gynecology ◽

10.18203/2320-1770.ijrcog20183785 ◽

2018 ◽

Vol 7 (9) ◽

pp. 3731

Author(s):

Divya Divya. ◽

Rupali Dewan

Keyword(s):

Clinical Outcome ◽

Removal Rate ◽

Contraceptive Devices ◽

Significant Difference ◽

Intrauterine Contraceptive ◽

Post Placental ◽

One Year ◽

Primiparous Women ◽

Continuation Rates

Background: The objective of the study was to compare the clinical outcome (safety, efficacy, expulsion and continuation rates) of post placental insertion of Cu375 and CuT380A intrauterine contraceptive devices (IUCD) in primiparous women undergoing caesarean section.Methods: This was a prospective, randomized comparative study in which 300 primiparous women were recruited. All these women had post placental intracaesarean insertion of CuT 380A or Cu375 IUCD. Follow up visits were scheduled at 1, 3 months, 6 month and 12 months.Results: Mean age was 23.1 years. Visibility of strings increased in successive follow up visits and was visible in 97.1% of women at the end of one year and 72.3% in CuT380A IUCD users at 12 months. Menorrhagia was reported in 8.6% in Cu375 IUCD users and 10% in CuT380A IUCD users at the end of 1 year of follow up. There were only 10 expulsions of Cu375 IUCD and six that of CuT380A IUCD. Removal rate in was 7.3% in Cu375 users and 6.7% in CuT380A users. Overall 84.7% of the women were satisfied with the treatment and 60% to an extent that they would like to recommend it to others whereas 15.3% were not satisfied at all either due to adverse events or spontaneous expulsion of IUCD.Conclusions: The Gross cumulative continuation rates was 86% in women with Cu375 IUCD insertions and 89.3% in CuT380A IUCD users. There was no significant difference between Cu375 and CuT380A regarding the safety, efficacy and complications.

Download Full-text